Questions about our services? (USA) 877-735-3648 Outside the US: 001-610-642-6055

Diabetes Bites Newsletter: May 2017

Diabetes Bites Newsletter: May 20172017-05-18T19:55:59-04:00

May 2017

1805, 2017

BG control in Type 1 Diabetes Improves with Fast-Acting Insulin Aspart

By |May 18th, 2017|

According to a study published online in Diabetes Care on April 11, fast-acting insulin aspart (faster aspart) improved blood glucose control in patients with Type 1 diabetes, as compared to the conventional formulation of the drug, insulin aspart (IAsp). In the United States, insulin aspart is better known as Novo Nordisk's insulin Novolog. In many other countries, it is known as NovoRapid.

Go to Top